Psoriasis: topical and systemic therapy.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000875:Anthralin / Q000627:therapeutic use; D003033:Coal Tar / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D010778:Photochemotherapy; D011565:Psoriasis / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D007641:Keratolytic Agents; D003033:Coal Tar; D000875:Anthralin; D006918:Hydroxyurea; D008727:Methotrexate